
Ana Victoria Rojo
@AVRMolBio
Followers
23
Following
18
Media
4
Statuses
14
Biologist🧬 PhD student in THD lab at KU Leuven Master in Biomolecules and Cell Dynamics in UAM
Leuven
Joined March 2023
Excited to present my research in #OARSI2024 in Vienna! Come check out my poster 614 about Kindlin-2 and it's role in OA 😊
0
1
9
Happy to present my data in the #BCR2023 this year! We got to be in an amazing location in De Bijloke in Ghent. @Eveline_vg_ gave a very interesting talk 😊. Looking forward for @AnaEscribano7 presentation tomorrow!!
1
3
13
RT @mujerconciencia: #HaceTresAños Cristina Escarmís, obrera de la investigación.Una entrevista de @juan___rojo y @AVRMolBio . https://t.co/….
0
5
0
First time presenting my research on Kindlin-2! Grateful to do it in SER OARSI 2023 in A Coruña! It was easy with the support from THD lab colleagues @NuriaViudes @Rocio_cv @AnaEscribano7 @AstridRoover
0
2
12
RT @NatRevRheumatol: New content online! Targeting KDM2/7 histone demethylases could protect against OA
0
2
0
RT @ReemAssi1: Check out our new review on intra-articular therapies for osteoarthritis just published in @DrugsJournal 💉.with @JolienQuint….
0
5
0
RT @SilviaMonteag: 📢 Check this interesting highlight @NatRevRheumatol of our lastest study on #epigenetics mechanisms and targets in #oste….
0
4
0
RT @OACJournal: Congratulations to @SilviaMonteag . for her Basic Science Research Publication of the Year Award in OAC 🏆.@TissueHomandDis….
0
4
0
RT @SilviaMonteag: Very excited to present our latest findings on #epigenetics in #cartilage and #osteoarthritis, just out in @ARD_BMJ Har….
0
5
0
RT @TissueHomandDis: Happy to share our new paper on #epigenetics in #osteoarthritis just published in @ardbmj with lead authors @ReemAssi1….
0
8
0
Exciting new paper from our group! Check it out in this thread⬇️⬇️.
Happy to share our new paper on #epigenetics in #osteoarthritis just published in @ardbmj with lead authors @ReemAssi1 @ChahrazadCHERI1 @TissueHomandDis @SilviaMonteag from @devreg @kuleuven in collaboration with @LUMC_Leiden (1/10).
0
0
3